Physiologically, β-
adrenoceptors are major regulators of lipid metabolism, which may be reflected in alterations in lipid droplet dynamics. β-
adrenoceptors have also been shown to participate in
breast cancer carcinogenesis. Since lipid droplets may be seen as a hallmark of
cancer, the present study aimed to investigate the role of β-
adrenoceptors in the regulation of lipid droplet dynamics in MCF-7
breast cancer cells. Cells were treated for up to 72 h with
adrenaline (an endogenous
adrenoceptor agonist),
isoprenaline (a non-selective β-
adrenoceptor agonist) and
salbutamol (a selective β2-selective agonist), and their effects on lipid droplets were evaluated using
Nile Red staining.
Adrenaline or
isoprenaline, but not
salbutamol, caused a
lipid-accumulating phenotype in the MCF-7 cells. These effects were significantly reduced by selective β1- and β3-antagonists (10 nM
atenolol and 100 nM
L-748,337, respectively), indicating a dependence on both β1- and β3-adrenoceptors. These effects were dependent on the cAMP signalling pathway, involving both
protein kinase A (PKA) and cAMP-dependent
guanine-nucleotide-exchange (
EPAC)
proteins: treatment with cAMP-elevating agents (forskolin or 8-Br-cAMP) induced lipid droplet accumulation, whereas either 1 µM
H-89 or 1 µM
ESI-09 (PKA or
EPAC inhibitors, respectively) abrogated this effect. Taken together, the present results demonstrate the existence of a β-
adrenoceptor-mediated regulation of lipid droplet dynamics in
breast cancer cells, likely involving β1- and β3-adrenoceptors, revealing a new mechanism by which
adrenergic stimulation may influence
cancer cell metabolism.